TECH — Bio-Techne

Life Sciences Tools & Services · Health Care

S&P 500 Timeline

2021-08-30Joined S&P 500
Bio-Techne, headquartered in Minnesota, is a life sciences manufacturer providing consumables and instruments for pharmaceutical, biotechnology, academic, and diagnostic markets. The company reports through two segments: Protein Sciences (approximately 75% of revenue) and Diagnostics and Genomics (25%). The Protein Sciences segment sells reagents and analytical instruments for life science research, including antibodies for protein analysis. The Diagnostics and Genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for approximately 55% of revenue. The company also operates in Europe, the Middle East, and

Key Facts

StatusActive
SectorHealth Care
IndustryLife Sciences Tools & Services
Joined2021-08-30
Tenure4 yrs

Industry Peers

Sector Peers

Institutional Holdings (13F)

585 institutions hold TECH, totaling 214.3M shares ($11.1B) · As of 2026Q1

RankInstitutionSharesValue
1MORGAN STANLEY24.1M$1.3B
2VANGUARD CAPITAL MANAGEMENT LLC20.4M$1.1B
3BlackRock, Inc.12.3M$641M
4FMR LLC7.9M$413M
5VANGUARD PORTFOLIO MANAGEMENT LLC6.5M$339M
6STATE STREET CORP5.9M$307M
7BARCLAYS PLC3.9M$277M
8WELLINGTON MANAGEMENT GROUP LLP5.1M$268M
9GEODE CAPITAL MANAGEMENT, LLC5.1M$267M
10MAVERICK CAPITAL LTD4.7M$248M

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10